- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Apr 29, 2026 | 14.42M sh |
| Shares Diluted | Q3 2026 · Mar 27, 2026 | 14.42M sh |
| Shares Diluted | Q3 2026 · Mar 27, 2026 | 14.31M sh |
| Shares Diluted | Q3 2026 · Mar 28, 2025 | 13.9M sh |
| Shares Diluted | Q3 2026 · Mar 28, 2025 | 13.84M sh |
| Dividends Paid | Q3 2026 · Mar 27, 2026 | $1.72M |
| Dividends Paid | Q3 2026 · Mar 28, 2025 | $1.7M |
| Capex | Q3 2026 · Mar 27, 2026 | $10.31M |
| Capex | Q3 2026 · Mar 28, 2025 | $7.45M |
| Operating Cash Flow | Q3 2026 · Mar 27, 2026 | $2.34M |
| Operating Cash Flow | Q3 2026 · Mar 28, 2025 | $7.53M |
| Long Term Debt | Q3 2026 · Mar 27, 2026 | $42.07M |
| Long Term Debt | Q3 2026 · Jun 30, 2025 | $28.45M |
| Stockholders Equity | Q3 2026 · Mar 27, 2026 | $185.66M |
| Stockholders Equity | Q3 2026 · Jun 30, 2025 | $164.01M |
| Current Liabilities | Q3 2026 · Mar 27, 2026 | $124.33M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $125.79M |
| Total Liabilities | Q3 2026 · Mar 27, 2026 | $204.49M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $191.17M |
| Current Assets | Q3 2026 · Mar 27, 2026 | $260.42M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $246.92M |
| Total Assets | Q3 2026 · Mar 27, 2026 | $391.02M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $355.56M |
| Total Assets | Q3 2026 · Mar 28, 2025 | $332.88M |
| Eps Diluted | Q3 2026 · Mar 27, 2026 | $0.23 |
| Eps Diluted | Q3 2026 · Mar 27, 2026 | $1.76 |
| Eps Diluted | Q3 2026 · Mar 28, 2025 | −$0.11 |
| Eps Diluted | Q3 2026 · Mar 28, 2025 | −$0.24 |
| Eps Basic | Q3 2026 · Mar 27, 2026 | $0.23 |
| Eps Basic | Q3 2026 · Mar 27, 2026 | $1.79 |
| Eps Basic | Q3 2026 · Mar 28, 2025 | −$0.11 |
| Eps Basic | Q3 2026 · Mar 28, 2025 | −$0.24 |
| Sga Expense | Q3 2026 · Mar 27, 2026 | $21.26M |
| Sga Expense | Q3 2026 · Mar 27, 2026 | $62.61M |
| Sga Expense restated | Q3 2026 · Mar 28, 2025 | $19.76M |
| Sga Expense restated | Q3 2026 · Mar 28, 2025 | $58.17M |
| Net Income | Q3 2026 · Mar 27, 2026 | $3.33M |
| Net Income | Q3 2026 · Mar 27, 2026 | $25.18M |
| Net Income | Q3 2026 · Mar 28, 2025 | −$1.47M |
| Net Income | Q3 2026 · Mar 28, 2025 | −$3.32M |
| Operating Income | Q3 2026 · Mar 27, 2026 | $5.82M |
| Operating Income | Q3 2026 · Mar 27, 2026 | $10.15M |
| Operating Income | Q3 2026 · Mar 28, 2025 | $1.95M |
| Operating Income | Q3 2026 · Mar 28, 2025 | $4.54M |
| Gross Profit | Q3 2026 · Mar 27, 2026 | $27.13M |
| Gross Profit | Q3 2026 · Mar 27, 2026 | $72.43M |
| Gross Profit | Q3 2026 · Mar 28, 2025 | $21.71M |
| Gross Profit | Q3 2026 · Mar 28, 2025 | $62.71M |
| Cost Of Revenue | Q3 2026 · Mar 27, 2026 | $69.56M |
| Cost Of Revenue | Q3 2026 · Mar 27, 2026 | $194.44M |
| Cost Of Revenue | Q3 2026 · Mar 28, 2025 | $59.54M |
| Cost Of Revenue | Q3 2026 · Mar 28, 2025 | $181.35M |
| Revenue | Q3 2026 · Mar 27, 2026 | $96.69M |
| Revenue | Q3 2026 · Mar 27, 2026 | $266.87M |
| Revenue | Q3 2026 · Mar 28, 2025 | $81.24M |
| Revenue | Q3 2026 · Mar 28, 2025 | $244.06M |